BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27068471)

  • 1. CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape.
    Wang Z; Pan Q; Gendron P; Zhu W; Guo F; Cen S; Wainberg MA; Liang C
    Cell Rep; 2016 Apr; 15(3):481-489. PubMed ID: 27068471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection.
    Yin L; Hu S; Mei S; Sun H; Xu F; Li J; Zhu W; Liu X; Zhao F; Zhang D; Cen S; Liang C; Guo F
    Hum Gene Ther; 2018 Nov; 29(11):1264-1276. PubMed ID: 29644868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial CRISPR-Cas9 and RNA Interference Attack on HIV-1 DNA and RNA Can Lead to Cross-Resistance.
    Zhao N; Wang G; Das AT; Berkhout B
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape.
    Wang G; Zhao N; Berkhout B; Das AT
    Mol Ther; 2016 Mar; 24(3):522-6. PubMed ID: 26796669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of HIV-1 Genetic Diversity on CRISPR-Cas9 Antiviral Activity and Viral Escape.
    Darcis G; Binda CS; Klaver B; Herrera-Carrillo E; Berkhout B; Das AT
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30871200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Combinatorial CRISPR-Cas9 Attack on HIV-1 DNA Extinguishes All Infectious Provirus in Infected T Cell Cultures.
    Wang G; Zhao N; Berkhout B; Das AT
    Cell Rep; 2016 Dec; 17(11):2819-2826. PubMed ID: 27974196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of infectious HIV DNA by CRISPR-Cas9.
    Das AT; Binda CS; Berkhout B
    Curr Opin Virol; 2019 Oct; 38():81-88. PubMed ID: 31450074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed
    Ophinni Y; Miki S; Hayashi Y; Kameoka M
    Viruses; 2020 Oct; 12(11):. PubMed ID: 33126728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.
    Lebbink RJ; de Jong DC; Wolters F; Kruse EM; van Ham PM; Wiertz EJ; Nijhuis M
    Sci Rep; 2017 Feb; 7():41968. PubMed ID: 28176813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
    Kennedy EM; Cullen BR
    Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudorabies virus can escape from CRISPR-Cas9-mediated inhibition.
    Peng Z; Ouyang T; Pang D; Ma T; Chen X; Guo N; Chen F; Yuan L; Ouyang H; Ren L
    Virus Res; 2016 Sep; 223():197-205. PubMed ID: 27507009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HSV-1 Replication by Gene Editing Strategy.
    Roehm PC; Shekarabi M; Wollebo HS; Bellizzi A; He L; Salkind J; Khalili K
    Sci Rep; 2016 Apr; 6():23146. PubMed ID: 27064617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed Gene Editing and Protein Overexpression Using a
    Cody WB; Scholthof HB; Mirkov TE
    Plant Physiol; 2017 Sep; 175(1):23-35. PubMed ID: 28663331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low incidence of SNVs and indels in trio genomes of Cas9-mediated multiplex edited sheep.
    Wang X; Liu J; Niu Y; Li Y; Zhou S; Li C; Ma B; Kou Q; Petersen B; Sonstegard T; Huang X; Jiang Y; Chen Y
    BMC Genomics; 2018 May; 19(1):397. PubMed ID: 29801435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the mechanisms underlying the inactivation of HIV-1 proviruses by CRISPR/Cas.
    Mefferd AL; Bogerd HP; Irwan ID; Cullen BR
    Virology; 2018 Jul; 520():116-126. PubMed ID: 29857168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated gene editing in an exogenous transgene and an endogenous sex determination gene in the Caribbean fruit fly, Anastrepha suspensa.
    Li J; Handler AM
    Gene; 2019 Apr; 691():160-166. PubMed ID: 30611840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of methods for effective identification of CRISPR/Cas9-induced indels in rice.
    Biswas S; Li R; Yuan Z; Zhang D; Zhao X; Shi J
    Plant Cell Rep; 2019 Apr; 38(4):503-510. PubMed ID: 30783736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
    Ophinni Y; Inoue M; Kotaki T; Kameoka M
    Sci Rep; 2018 May; 8(1):7784. PubMed ID: 29773895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.